(JANX) Janux Therapeutics - Performance -40.7% in 12m
JANX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-4.19%
#34 in Peer-Group
Rel. Strength
13.38%
#6657 in Stock-Universe
Total Return 12m
-40.74%
#108 in Peer-Group
Total Return 5y
2.43%
#33 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 66.84 USD |
| 52 Week Low | 22.62 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 73.66 |
| Buy/Sell Signal +-5 | -0.94 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: JANX (-40.7%) vs XBI (-14%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
-1.6% | 59% | 71.9% | 24.1 | 14.3 | 0.24 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
1.62% | -10.4% | 150% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-1.03% | -8.54% | 32.3% | 27.4 | 14.2 | 0.99 | 0.60% | 41% |
| NBIX NASDAQ Neurocrine Biosciences |
4.99% | -11% | 0.55% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| BIM PA Biomerieux |
-2.07% | 25.1% | -6.95% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
5.73% | 34.5% | -14.4% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-7.94% | 44.1% | -14.3% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
-1.57% | 27.9% | 14.5% | 28.8 | 15.2 | 0.63 | -62.1% | -19.3% |
Performance Comparison: JANX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for JANX
| Total Return (including Dividends) | JANX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 9.11% | 3.06% | 3.54% |
| 3 Months | -11.36% | 12.25% | 16.07% |
| 12 Months | -40.74% | -13.98% | 12.18% |
| 5 Years | 2.43% | -27.36% | 107.69% |
| Trend Score (consistency of price movement) | JANX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 68.3% | 76.5% | 91.9% |
| 3 Months | -62.2% | 79.3% | 97.5% |
| 12 Months | -72.7% | -87.3% | 47% |
| 5 Years | 37.5% | -51.7% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th69.50 | 5.87% | 5.38% |
| 3 Month | %th18.50 | -21.03% | -23.63% |
| 12 Month | %th46.00 | -31.11% | -47.17% |
| 5 Years | %th86.50 | 61.66% | -34.20% |
FAQs
Does Janux Therapeutics (JANX) outperform the market?
No,
over the last 12 months JANX made -40.74%, while its related Sector, the SPDR S&P Biotech (XBI) made -13.98%.
Over the last 3 months JANX made -11.36%, while XBI made 12.25%.
Performance Comparison JANX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
JANX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 5.1% | 5.6% | -46.9% | -53% |
| US NASDAQ 100 | QQQ | 4.6% | 4.8% | -49.4% | -54% |
| German DAX 40 | DAX | 6% | 7.6% | -57.7% | -69% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 4.5% | 4.2% | -51% | -60% |
| Hongkong Hang Seng | HSI | 4.5% | 6.7% | -68.9% | -75% |
| India NIFTY 50 | INDA | 6.8% | 8.5% | -48.4% | -37% |
| Brasil Bovespa | EWZ | 9.7% | 12.1% | -59% | -41% |
JANX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 6.1% | 7.3% | -51.1% | -64% |
| Consumer Discretionary | XLY | 4.7% | 6.5% | -38.2% | -56% |
| Consumer Staples | XLP | 6.9% | 9.9% | -47.7% | -47% |
| Energy | XLE | 7.2% | 9.4% | -36.7% | -38% |
| Financial | XLF | 6.4% | 6.5% | -46.5% | -63% |
| Health Care | XLV | 7.1% | 10.9% | -36.5% | -32% |
| Industrial | XLI | 4.7% | 4.4% | -52.8% | -62% |
| Materials | XLB | 7.7% | 7.4% | -44.8% | -41% |
| Real Estate | XLRE | 5.6% | 9.7% | -45.7% | -47% |
| Technology | XLK | 4.7% | 2.8% | -52.8% | -52% |
| Utilities | XLU | 4.3% | 7.2% | -49.6% | -62% |
| Aerospace & Defense | XAR | 2.2% | -0.1% | -67.5% | -90% |
| Biotech | XBI | 3.9% | 6.1% | -38.4% | -27% |
| Homebuilder | XHB | 6.8% | 3.6% | -33.6% | -34% |
| Retail | XRT | 6.3% | 6.2% | -42.8% | -46% |
JANX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 7.6% | 13.4% | -30.6% | -35% |
| Natural Gas | UNG | 0.6% | 17.6% | -22.6% | -48% |
| Gold | GLD | 4.5% | 10.7% | -64.6% | -78% |
| Silver | SLV | 2.5% | 5.4% | -63.9% | -63% |
| Copper | CPER | 3.8% | -4.5% | -65.7% | -63% |
JANX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 6.6% | 9.3% | -41.5% | -36% |
| iShares High Yield Corp. Bond | HYG | 5.5% | 8.2% | -45% | -49% |